p38β-Mediated BiP Phosphorylation Drives Stemness, Chemoresistance by Suppressing UPR in Liver Cancer
Hepatocellular carcinoma, the most common primary cancer of the liver, is notoriously difficult to treat once it becomes advanced. Even ...
Hepatocellular carcinoma, the most common primary cancer of the liver, is notoriously difficult to treat once it becomes advanced. Even ...
Oxaliplatin, a platinum-based chemotherapy drug, is a cornerstone in the treatment regimen for patients diagnosed with colon cancer (CC). However, ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine